Table of Content



1. Executive Summary

2. Global Biomarker Market : Market Dynamics
2.1: Introduction, Background, and Classifications
2.2: Supply Chain
2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030
3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
3.2. Global Biomarker Market Trends (2018-2023) and Forecast (2024-2030)
3.3: Global Biomarker Market by Product
3.3.1: Consumables
3.3.2: Services
3.3.3: Software
3.4: Global Biomarker Market by Type
3.4.1: Safety Biomarkers
3.4.2: Efficacy Biomarkers
3.4.3: Predictive Biomarkers
3.4.4: Surrogate Biomarkers
3.4.5: Pharmacodynamics Biomarkers
3.4.6: Prognostic Biomarkers
3.4.7: Validation Biomarkers
3.5: Global Biomarker Market by Disease Indication
3.5.1: Cancer
3.5.2: Infectious Diseases
3.5.3: Immune Disorders
3.5.4: Neurological Disorders
3.5.5: Cardiovascular Disorders
3.5.6: Others
3.6: Global Biomarker Market by Application
3.6.1: Diagnostics
3.6.2: Drug Discovery & Development
3.6.3: Personalized Medicine
3.6.4: Disease Risk Assessment
3.6.5: Others

4. Market Trends and Forecast Analysis by Region from 2018 to 2030
4.1: Global Biomarker Market by Region
4.2: North American Biomarker Market
4.2.1: North American Market by Product: Consumables, Services, and Software
4.2.2: North American Market by Application: Diagnostics, Drug Discovery & Development, Personalized Medicine, Disease Risk Assessment, and Others
4.3: European Biomarker Market
4.3.1: European Market by Product: Consumables, Services, and Software
4.3.2: European Market by Application: Diagnostics, Drug Discovery & Development, Personalized Medicine, Disease Risk Assessment, and Others
4.4: APAC Biomarker Market
4.4.1: APAC Market by Product: Consumables, Services, and Software
4.4.2: APAC Market by Application: Diagnostics, Drug Discovery & Development, Personalized Medicine, Disease Risk Assessment, and Others
4.5: ROW Biomarker Market
4.5.1: ROW Market by Product: Consumables, Services, and Software
4.5.2: ROW Market by Application: Diagnostics, Drug Discovery & Development, Personalized Medicine, Disease Risk Assessment, and Others

5. Competitor Analysis
5.1: Product Portfolio Analysis
5.2: Operational Integration
5.3: Porter’s Five Forces Analysis

6. Growth Opportunities and Strategic Analysis
6.1: Growth Opportunity Analysis
6.1.1: Growth Opportunities for the Global Biomarker Market by Product
6.1.2: Growth Opportunities for the Global Biomarker Market by Type
6.1.3: Growth Opportunities for the Global Biomarker Market by Disease Indication
6.1.4: Growth Opportunities for the Global Biomarker Market by Application
6.1.5: Growth Opportunities for the Global Biomarker Market by Region
6.2: Emerging Trends in the Global Biomarker Market
6.3: Strategic Analysis
6.3.1: New Product Development
6.3.2: Capacity Expansion of the Global Biomarker Market
6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Biomarker Market
6.3.4: Certification and Licensing

7. Company Profiles of Leading Players
7.1: Abbott Laboratories
7.2: QIAGEN
7.3: PerkinElmer
7.4: Merck
7.5: Bio-Rad Laboratories
7.6: Enzo Biochem
7.7: Charles River Laboratories
7.8: Siemens
7.9: Epistem
7.10: Eurofins Scientific